资讯

2025年,全球mRNA疫苗累计接种已超百亿剂次,其高效性与安全性彻底改写了传染病防控的格局。从新冠疫苗到癌症治疗,mRNA技术正以惊人的速度渗透医学领域。然而,回溯至2005年,科学家Karikó团队首次发现,将mRNA中的尿苷(U)替换为假尿苷( ...
Geneoscopy wins PTAB ruling as all 20 claims of Exact Sciences’ ’781 patent are invalidated, paving the way for continued advancement of ColoSense.
To build proteins, cells rely on a molecule called transfer RNA, or tRNA. tRNAs act like protein-building couriers, where ...
The rapid identification of respiratory virus outbreaks is needed to enable rational and effective public health interventions. We developed new quantitative approaches for simultaneous ...
To build proteins, cells rely on a molecule called transfer RNA, or tRNA. tRNAs act like protein-building couriers, where ...
Single-cell RNA-seq (scRNA-seq) has spent the past decade maturing into a foundational technology. Over that time, the ...
To build proteins, cells rely on a molecule called transfer RNA, or tRNA. tRNAs act like protein-building couriers, where ...
The FDA approves a rapid test for identifying patients with NSCLC eligible for sunvozertinib, enhancing timely, precision ...
Viome partners with Microsoft to scale its RNA-based health platform, using AI and cloud computing to deliver personalized ...